Citius Oncology, INC. (CTOR) SEC Filings — 2025
22 SEC filings for Citius Oncology, INC. (CTOR) in 2025.
Filings
- Citius Oncology Launches LYMPHIR Amidst Going Concern Doubts — 10-K · Dec 23, 2025
- Citius Oncology Files 8-K: Material Agreement, Equity Sales — 8-K · Dec 10, 2025
- Citius Oncology Files 8-K Report — 8-K · Dec 1, 2025
- Citius Oncology Files 8-K: Director Changes, Officer Comp, Shareholder Votes — 8-K · Oct 27, 2025
- Citius Oncology Files 8-K Report — 8-K · Oct 23, 2025
- CTOR Seeks Share Dilution, Board Re-election at Oct. 27 Meeting — DEF 14A · Sep 26, 2025
- Citius Oncology Files 8-K: Equity Sale, Officer Changes, Financials — 8-K · Sep 19, 2025
- Citius Oncology Files 8-K with Key Agreements and Disclosures — 8-K · Sep 10, 2025
- Citius Oncology Files 8-K Report — 8-K · Aug 18, 2025
- Citius Oncology's Losses Mount, Cash Dwindles Amid Going Concern Doubts — 10-Q · Aug 12, 2025
- Citius Oncology Files 8-K: Material Agreement and Other Events — 8-K · Jul 18, 2025
- Citius Oncology Amends S-1 for Continuous Offering — S-1/A · Jul 14, 2025
- Citius Oncology Files 8-K: Other Events — 8-K · Jun 27, 2025
- Citius Oncology Files 8-K Report — 8-K · Jun 17, 2025
- Citius Oncology Files Q1 2025 10-Q Report — 10-Q · May 14, 2025
- Citius Oncology Faces Delisting Concerns — 8-K · Apr 25, 2025
- Citius Oncology Enters Material Definitive Agreement — 8-K · Apr 3, 2025
- Citius Oncology Files Q4 2024 10-Q Report — 10-Q · Feb 14, 2025
- Citius Oncology Files 8-K Report — 8-K · Feb 6, 2025
- Citius Oncology Files 10-K/A Amendment — 10-K/A · Jan 27, 2025
- Citius Oncology Files 8-K Report — 8-K · Jan 7, 2025
- Citius Oncology Files 8-K Report — 8-K · Jan 6, 2025